510(k) K081251
K081251 is an FDA 510(k) premarket notification submitted by Aesku Diagnostics for the device "MODIFICATION TO AESKULISA DS DNA G". The FDA issued a decision of Substantially Equivalent on May 13, 2008. The device falls under product code LSW (Anti-Dna Antibody, Antigen And Control), a Class II device regulated under 21 CFR 866.5100. Aesku Diagnostics has at least 8 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 13, 2008
- Date Received
- May 2, 2008
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- Yes
Device Classification
- Device Name
- Anti-Dna Antibody, Antigen And Control
- Device Class
- Class II
- Regulation Number
- 866.5100
- Review Panel
- IM
- Submission Type